
First-of-its-kind consortium dedicated to accelerating new medicines development through optimizing patient advocacy group—industry collaboration.

First-of-its-kind consortium dedicated to accelerating new medicines development through optimizing patient advocacy group—industry collaboration.

Tufts CSDD survey finds fostering healthy relationships with site staff is key to a positive outlook.

Study by Tufts CSDD uncovers potential reasons behind CRA shortages, turnover, experience requirements, and more.

Tufts CSDD study in collaboration with ten biopharmaceutical organizations and CROs examines sponsor/CRO relationships.